Remed Co., Ltd. (302550) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Remed Co., Ltd. (302550:KRX), powered by AI.

Current Price
₩2,970
P/E Ratio
174.4
Market Cap
91.8B
Sector
Healthcare
What is the Remed Co., Ltd. stock price forecast?

Remed Co., Ltd. is currently trading at ₩2,970. View real-time AI analysis on Alpha Lenz.

What is Remed Co., Ltd. insider trading activity?

View the latest insider trading data for Remed Co., Ltd. on Alpha Lenz.

What is Remed Co., Ltd.'s P/E ratio?

Remed Co., Ltd.'s P/E ratio is 174.4.

Remed Co., Ltd.

KRX · 302550
₩2,970+10(+0.34%)Market closedKRX regular session 09:00–15:30 KST
Ask about Remed Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Remed Co., Ltd. trades at a P/E of 174.4 (premium valuation) with modest ROE of 1.3%.

Ask for details

Company Overview

Remed Co., Ltd., a prominent company in the healthcare sector, primarily focuses on the development and manufacture of medical devices and health solutions. The company's core operations include designing advanced medical equipment, such as electromagnetic stimulators, which are pivotal in physiotherapy and pain management. Remed Co., Ltd. has carved a niche in the market by integrating advanced technology into their medical devices, addressing the needs of both healthcare professionals and patients. With a significant emphasis on research and development, the company continually innovates to enhance the efficacy and accessibility of its products. Remed Co., Ltd. plays a crucial role in improving patient care standards globally, serving hospitals, clinics, and wellness centers. Building a strong market presence, the company contributes to advancing medical technology through its diverse portfolio, thereby supporting the healthcare industry's growth and evolution.

CEO이근용
SectorHealthcare
IndustryMedical Devices
Employees89

Company Statistics

FY 2025

Profile

₩91,794,235,500Market Cap
₩24,504,879,370Revenue
30.91MShares Out
89Employees

Margins

57.46%Gross
10.44%EBITDA
2.96%Operating
-1.22%Pre-Tax
-0.14%Net

Valuation

174.45P/E
2.29P/B
3.75EV/Sales
34.46EV/EBITDA
60.09P/FCF

Growth (CAGR)

4.68%Rev 3Yr
8.06%Rev 5Yr
-24.12%Op Inc 3Yr
-15.49%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-0.06%ROA
1.31%ROE
1.02%ROIC

Financial Health

₩8,470,020,000Cash & Cash Equivalents
₩5,975,286,680Net Debt
36.60%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Remed Co., Ltd. (ticker: 302550) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 89 employees. Market cap is $91.8B.

The current price is ₩2,970 with a P/E ratio of 174.45x and P/B of 2.29x.

ROE is 1.31% and operating margin is 2.96%. Annual revenue is $24.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Remed Co., Ltd. (302550) Stock Forecast 2026 ₩2,970 — Price, Financials & Analyst Targets | Alpha Lenz